BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 30358274)

  • 1. [With the Characteristics of Chronic Pain Patients, Can the Therapeutic Effect of Antidepressant Duloxetine be Predicted?].
    Enomoto T; Sugita M; Katsuta Y; Hori N; Koh K; Saito R; Hasegawa R; Takahashi Y; Sugasawa Y; Yamaguchi K; Isek M; Inada E
    Masui; 2016 Oct; 65(10):1005-1008. PubMed ID: 30358274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
    Lewis-Fernández R; Lam P; Lucak S; Galfalvy H; Jackson E; Fried J; Rosario M; de la Cruz AA; Sánchez-Lacay A; Díaz S; Schneier F
    J Clin Psychopharmacol; 2016 Dec; 36(6):710-715. PubMed ID: 27755218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the Effects of Sertraline with Duloxetine for Depression Severity and Symptoms: A Double-Blind, Randomized Controlled Trial.
    Mowla A; Dastgheib SA; Razeghian Jahromi L
    Clin Drug Investig; 2016 Jul; 36(7):539-43. PubMed ID: 27071759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine plasma level and antidepressant response.
    De Donatis D; Florio V; Porcelli S; Saria A; Mercolini L; Serretti A; Conca A
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():127-132. PubMed ID: 30611837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and long-term treatment of late-life major depressive disorder: duloxetine versus placebo.
    Robinson M; Oakes TM; Raskin J; Liu P; Shoemaker S; Nelson JC
    Am J Geriatr Psychiatry; 2014 Jan; 22(1):34-45. PubMed ID: 24314888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.
    Raskin J; Wiltse CG; Siegal A; Sheikh J; Xu J; Dinkel JJ; Rotz BT; Mohs RC
    Am J Psychiatry; 2007 Jun; 164(6):900-9. PubMed ID: 17541049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?
    Marchettini P; Wilhelm S; Petto H; Tesfaye S; Tölle T; Bouhassira D; Freynhagen R; Cruccu G; Lledó A; Choy E; Kosek E; Micó JA; Späth M; Skljarevski V; Lenox-Smith A; Perrot S
    Eur J Pain; 2016 Mar; 20(3):472-82. PubMed ID: 26311228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C
    Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vortioxetine versus Duloxetine in the Treatment of Patients with Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials.
    Li G; Wang X; Ma D
    Clin Drug Investig; 2016 Jul; 36(7):509-17. PubMed ID: 27067232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the geriatric anxiety inventory in a duloxetine clinical trial for elderly adults with generalized anxiety disorder.
    Ball SG; Lipsius S; Escobar R
    Int Psychogeriatr; 2015 Sep; 27(9):1533-9. PubMed ID: 25925598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDNF plasma levels variations in major depressed patients receiving duloxetine.
    Fornaro M; Escelsior A; Rocchi G; Conio B; Magioncalda P; Marozzi V; Presta A; Sterlini B; Contini P; Amore M; Fornaro P; Martino M
    Neurol Sci; 2015 May; 36(5):729-34. PubMed ID: 25501804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
    Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
    J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duloxetine in elderly major depression disorder: effectiveness and drug plasma level evaluation.
    Rovera C; Mauri MC; Bertin E; Di Pace C; Paletta S; Reggiori A; De Gaspari IF; Cattaneo D; Mari D; Altamura AC
    Hum Psychopharmacol; 2016 Sep; 31(5):349-55. PubMed ID: 27400882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine Plasma Concentrations and Its Effectiveness in the Treatment of Nonorganic Chronic Pain in the Orofacial Region.
    Kobayashi Y; Nagashima W; Tokura T; Yoshida K; Umemura E; Miyauchi T; Arao M; Ito M; Kimura H; Kurita K; Ozaki N
    Clin Neuropharmacol; 2017; 40(4):163-168. PubMed ID: 28622208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials.
    Nelson JC
    Depress Anxiety; 2010; 27(1):12-8. PubMed ID: 20013987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
    Wade AG; Fernández JL; François C; Hansen K; Danchenko N; Despiegel N
    Pharmacoeconomics; 2008; 26(11):969-81. PubMed ID: 18850765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroretinographic assessment in major depressed patients receiving duloxetine: might differences between responders and non-responders indicate a differential biological background?
    Fornaro M; Bandini F; Ogliastro C; Cordano C; Martino M; Cestari L; Escelsior A; Rocchi G; Colicchio S; Perugi G
    J Affect Disord; 2011 Dec; 135(1-3):154-9. PubMed ID: 21820182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
    Shelton RC; Prakash A; Mallinckrodt CH; Wohlreich MM; Raskin J; Robinson MJ; Detke MJ
    Int J Clin Pract; 2007 Aug; 61(8):1337-48. PubMed ID: 17627710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.